Frazier Life Sciences Ix, L.P. is > 10% Shareholder of Tarsus Pharmaceuticals, Inc.. Currently has a direct ownership of 1.92 Million shares of TARS, which is worth approximately $73.3 Million. The most recent transaction as insider was on Oct 20, 2020, when has been sold 312,500 shares (Common Stock) at a price of $16.0 per share, resulting in proceeds of $5,000,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.92M
0% 3M change
0% 12M change
Total Value Held $73.3 Million

Frazier Life Sciences IX, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 20 2020
Open market or private purchase
$5,000,000 $16.0 p/Share
312,500 Added 14.02%
1,917,157 Common Stock
Oct 20 2020
Conversion of derivative security
1,604,657 Added 50.0%
1,604,657 Common Stock

Frazier Life Sciences Ix, L.P.

> 10% Shareholder
Seattle, WA

Track Institutional and Insider Activities on TARS

Follow Tarsus Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TARS shares.

Notify only if

Insider Trading

Get notified when an Tarsus Pharmaceuticals, Inc. insider buys or sells TARS shares.

Notify only if


Receive news related to Tarsus Pharmaceuticals, Inc.

Track Activities on TARS